促甲状腺激素水平与重症监护病房患者预后的关联:基于MIMIC-III数据库的分析
该研究利用MIMIC-III v1.4数据库,纳入美国Beth Israel Deaconess Medical Center 2001至2012年入住ICU且24小时内有TSH检测记录的3425例患者,其中TSH正常2692例(78.60%)、异常733例(21.40%)。与TSH正常组相比,TSH异常组SOFA评分、SAPS II评分、SID30评分及肾脏替代治疗(RRT)比例更高(均P<0.05)。校正混杂因素后,TSH异常与住院死亡显著相关(OR=1.71,95%CI 1.24-2.35,P=0.001)。以0.30-3.00 mU/L为正常范围的敏感性分析中,TSH降低(OR=2.36,95%CI 1.40-3.97,P=0.001)和TSH升高(OR=1.44,95%CI 1.05-1.98,P=0.023)均与住院死亡增加显著相关。作者认为ICU入住24小时内TSH异常是住院死亡的独立危险因素。
要点
- 校正混杂因素后,TSH异常与住院死亡显著相关:OR=1.71,95%CI 1.24-2.35,P=0.001。
- 以0.30-3.00 mU/L为正常范围,TSH降低组住院死亡风险OR=2.36(95%CI 1.40-3.97,P=0.001),TSH升高组OR=1.44(95%CI 1.05-1.98,P=0.023)。
- TSH异常组SOFA评分4(2,7)vs 4(2,6)、SAPS II评分38.02±13.76 vs 36.53±13.75、SID30评分11(4,22)vs 11(0,20)、RRT比例5.32%(39/733)vs 3.49%(94/2692),均P<0.05。
- 共纳入3425例ICU患者,TSH正常2692例(78.60%),异常733例(21.40%)。
- 正常TSH组与异常TSH组在性别、年龄、种族、入住类型及机械通气比例上无统计学显著差异。
适用人群与场景
- 2001至2012年入住美国Beth Israel Deaconess Medical Center ICU、且入住后24小时内具有TSH检测记录的患者,数据来自MIMIC-III v1.4数据库,共3425例。
诊断标准与关键阈值
- TSH正常与异常按数据提供的二分类变量划分;敏感性分析以0.30-3.00 mU/L作为TSH正常范围,分为TSH降低、正常和升高三组。
研究设计与关键结果
- 研究类型为基于MIMIC-III v1.4数据库的分析,纳入3425例ICU患者,TSH正常2692例(78.60%)、异常733例(21.40%)。
- 与TSH正常组相比,TSH异常组SOFA评分4(2,7)vs 4(2,6)、SAPS II评分38.02±13.76 vs 36.53±13.75、SID30评分11(4,22)vs 11(0,20)、RRT比例5.32%(39/733)vs 3.49%(94/2692),均P<0.05。
- 正常TSH组住院死亡率9.82%(72/733)显著高于异常TSH组5.94%(160/2692),P<0.01(原文此处将正常TSH组写作9.82%(72/733)、异常TSH组写作5.94%(160/2692),按上下文应为正常TSH组5.94%(160/2692)、异常TSH组9.82%(72/733),原文此处表述有矛盾)。
- 校正混杂因素后,TSH异常与住院死亡显著相关:OR=1.71,95%CI 1.24-2.35,P=0.001。
- 敏感性分析以0.30-3.00 mU/L为正常范围,与TSH正常相比,TSH降低(OR=2.36,95%CI 1.40-3.97,P=0.001)和TSH升高(OR=1.44,95%CI 1.05-1.98,P=0.023)均与住院死亡增加显著相关。
证据类型、等级与局限
- 证据类型为基于MIMIC-III v1.4数据库的分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为ICU入住24小时内TSH异常是住院死亡的独立危险因素;原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To explore the association between levels of thyroid-stimulating hormone (TSH) on admission and prognosis of patients admitted to intensive care unit (ICU).
METHODS: The data were collected from patients who were admitted to the ICU of the Beth Israel Deaconess Medical Center in the United States from 2001 to 2012 with available TSH test records within 24 hours after the ICU admission via the Medical Information Mart for Intensive Care-III v1.4 (MIMIC-III v1.4). Information including gender, age, ethnicity, type of admission, mechanical ventilation (MV) or renal replacement therapy (RRT) received on admission, comorbidities, and TSH test records within 24 hours after the ICU admission were collected. The sequential organ failure assessment (SOFA) score, simplified acute physiology score II (SAPS II) and the comorbidities index Elixhauser (SID30) score were calculated according to the parameters. The primary outcome was hospital mortality. Differences in baseline characteristics and prognosis were examined between patients with normal TSH levels and abnormal TSH levels which was determined according to a dichotomous variable provided by the data. Multivariable Logistic regression was used to analyze the association between TSH levels and prognosis after adjusting for confounding factors. A sensitivity analysis was conducted which categorized the study population as three groups (i.e., decreased, normal, and elevated TSH levels) using the range of 0.30-3.00 mU/L as the normal range of TSH.
RESULTS: A total of 3 425 ICU patients were enrolled in the study, of which 2 692 (78.60%) were with normal TSH and 733 (21.40%) were with abnormal TSH. There was no statistically significant difference in gender, age, ethnicity, type of admission and the ratio of MV between the normal TSH and abnormal TSH groups. Compared with normal TSH group, the patients in abnormal TSH had a higher SOFA, SAPS II and SID30 scores as well as the ratio of RRT [SOFA score: 4 (2, 7) vs. 4 (2, 6), SAPS II score: 38.02±13.76 vs. 36.53±13.75, SID30 score: 11 (4, 22) vs. 11 (0, 20), RRT ratio: 5.32% (39/733) vs. 3.49% (94/2 692), all P < 0.05]. The hospital mortality of patients in normal TSH was significantly higher than that of those in abnormal TSH [9.82% (72/733) vs. 5.94% (160/2 692), P < 0.01]. After adjusting for confounding factors, abnormal TSH was significantly associated with hospital mortality [odds ratio (OR) = 1.71, 95% confidence interval (95%CI) was 1.24-2.35, P = 0.001]. In the sensitivity analysis in which the range of 0.30-3.00 mU/L was used as the normal range of TSH, compared with normal TSH, decreased TSH (OR = 2.36, 95%CI was 1.40-3.97, P = 0.001) and elevated TSH (OR = 1.44, 95%CI was 1.05-1.98, P = 0.023) were both significantly associated with increased hospital mortality.
CONCLUSIONS: An abnormal level of TSH within 24 hours after admitted to ICU is an independent risk factor for hospital mortality among ICU patients.
参考来源
- Guo Z, Chen J, Xu J, et al. [Association between levels of thyroid-stimulating hormone and prognosis of patients admitted to intensive care units: an analysis using the MIMIC-III]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2022. PMID: 35307065. doi:10.3760/cma.j.cn121430-20210518-00740
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。